আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
movicol junior neutral mixtúruduft, lausn 6,9 g
norgine healthcare b.v. - macrogol 3350; sodium hydrogen carbonate; kalii chloridum; sodium chloride - mixtúruduft, lausn - 6,9 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
movicol mixtúruduft, lausn 13,8 g
norgine healthcare b.v. - macrogol 3350; sodium chloride; sodium hydrogen carbonate; kalii chloridum - mixtúruduft, lausn - 13,8 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
moviprep mixtúruduft, lausn
norgine b.v. - macrogol 3350; natrii sulfas; natrii chloridum; kalii chloridum; acidum ascorbicum inn; natrii ascorbas inn - mixtúruduft, lausn
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
plenvu mixtúruduft, lausn
norgine b.v. - macrogol 3350; natrii ascorbas inn; sodium sulfate anhydrous; acidum ascorbicum inn; natrii chloridum; kalii chloridum - mixtúruduft, lausn
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
rydapt
novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - Æxlishemjandi lyf - rydapt er ætlað:í bland með venjulegu daunorubicin og cýtarabín framkalla og stóran skammt cýtarabín sameiningu lyfjameðferð, og fyrir sjúklinga í fylltu svar eftir rydapt einn umboðsmaður viðhald meðferð, fyrir fullorðna sjúklinga með nýlega greind bráð merg hvítblæði (aml) sem eru flt3 stökkbreytingu jákvætt (sjá kafla 4. 2);eitt og sér fyrir meðferð fullorðinn sjúklinga með árásargjarn almenn mastfrumnager (hjÁ), almenn mastfrumnager með tilheyrandi blóðfræðileg æxli (sm do), eða mastur klefi hvítblæði (sáust oftar).
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
emla (emla) krem 25+25 mg/g
aspen pharma trading limited - lidocainum inn; prilocainum inn - krem - 25+25 mg/g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
fixopost (monoprostduo) augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml
laboratoires thea* - latanoprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml + 5 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 100 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 25 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 25 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 50 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 50 mg